about
The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activitiesDysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice.CD40L and Its Receptors in Atherothrombosis-An UpdateIn vivo targeted delivery of CD40 shRNA to mouse intestinal dendritic cells by oral administration of recombinant Sacchromyces cerevisiae.CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunityPlatelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk.Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.The roles of buyang huanwu decoction in anti-inflammation, antioxidation and regulation of lipid metabolism in rats with myocardial ischemia.Protective effects of chinese traditional medicine buyang huanwu decoction on myocardial injury.Effect of fluid shear stress on portal vein remodeling in a rat model of portal hypertension.Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome.CD40 ligand: a novel target in the fight against cardiovascular disease.Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis.Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway.Platelets, inflammation, and atherothrombotic neurovascular disease: the role of endothelial dysfunction.Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cellsPlatelet-lymphocyte cross-talk.Prenatal exposure to cigarette smoke induces diet- and sex-dependent dyslipidemia and weight gain in adult murine offspringInflammatory cytokines in vascular dysfunction and vascular disease.Human immunodeficiency virus (HIV) type 1 Vpu induces the expression of CD40 in endothelial cells and regulates HIV-induced adhesion of B-lymphoma cells.Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosis.Regulation of platelet membrane protein shedding in health and disease.Interaction of CD154 with different receptors and its role in bidirectional signals.Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.Pentoxifylline decreases soluble CD40 ligand concentration and CD40 gene expression in coronary artery disease patients.T-cell co-stimulators as anti-inflammatory targets for atherosclerotic disease.Higher frequencies of circulating ICOS(+), IL-21(+) T follicular helper cells and plasma cells in patients with new-onset membranous nephropathy.Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats.CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis.Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome.CD40-dependent activation of phosphatidylinositol 3-kinase/AKT pathway inhibits apoptosis of human cultured mesangial cells induced by oxidized LDL.Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products.Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.Is primary hyperparathyroidism a cause of endothelial dysfunction?Propolis and swimming in the prevention of atherogenesis and left ventricular hypertrophy in hypercholesterolemic mice.Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot study.Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.Chemokines and atherosclerosis
P2860
Q28513582-0F69216B-B2EE-4539-8452-C7C9CCA43F03Q30405805-E2BD1F6D-5FE2-4D26-A936-19AE5148D9E8Q33814059-AB0B8737-3AE8-4D7F-AD0A-EE1DD8D2B8E4Q33863257-079B8C20-4B3A-4910-98B0-47AE2A624246Q34054070-673C6AA6-BFD2-43FE-8E59-23C733DB8C00Q34549341-1BCD1399-BAAF-4168-A469-C53655E5CC12Q34618889-9B13C8ED-48C7-499A-A0C7-F43E1F0E747EQ35106421-96BC6BFB-59FC-4D49-AD25-FF28FE55A919Q35112436-EE8B272C-8784-43CC-9253-B20241C85F7AQ35373336-FE776077-B0D4-46FF-BAF5-2F1E2F0E5145Q35576410-EB40BD68-87F1-4EFF-95B3-A1FF5C86627AQ35848866-312D1935-62CF-4AEE-A711-AF4400E7C09EQ35952305-66BFB785-C58C-439B-BD66-405DD663BAF5Q36000924-A212180A-A3C5-4592-BB1B-1AECC8978716Q36331005-1130F88E-D2DC-4D2E-99DB-94BEB6BC971FQ36941078-D431C817-3162-4690-A054-5F9B4BA3BFF2Q37058252-C073214B-FBE0-4EE8-ACA5-D1C9D66CDC99Q37278921-C909EC35-3606-4B75-B026-283D0C925FACQ37315106-4A5CF544-9222-4A43-8D70-42DC6EA09776Q37422645-359B47A4-3D86-4FFD-A0E3-9723553865C0Q37866127-E1629701-F7FD-4F2C-93E7-6EB038437FD4Q38919547-42CC751E-B0C3-4151-A44F-10263DC629EFQ38939816-0EB51E8B-60A3-4342-818C-4435724278FBQ39215639-5D67DD1D-C2A4-4030-85BC-EA8AAB4ADC8EQ39697415-8F18AD3C-A9ED-4983-9055-701D133865B9Q40347857-0263BBC4-A2F9-4AE8-9CFF-6EBD3BBE2710Q43168259-AA57CE46-3209-470E-8D1F-D9B0590F336DQ43836602-75CB276A-70B7-4774-A575-C106D1493A40Q44362136-D001CB1B-616A-4FE9-A6E2-EA2FD71DC232Q46275241-3DD7F731-E0F6-4D29-95FA-659C3B16AD47Q46485754-558D9F04-B63C-4954-98FB-5AFA25E749F2Q46820939-964D290B-88AF-46FB-BBD9-76D9BB6D5A5DQ47224948-02C852C9-312F-491A-A3EF-73E1BCCB5D9DQ48161049-0A8F9C33-DF98-44DC-BE39-894CB834646CQ50441470-6E2A783D-E0FD-4631-A5D0-BDE79EA7576CQ51486964-6012776B-35A4-483D-BCA2-DF1924016F8CQ51498412-75562C5E-9EC5-4961-946B-B758D9DE137BQ52949259-3F147217-CC37-4C0C-B7AB-2FD51ABE350FQ58246532-221431DE-B016-4270-A8D0-481A6EFECC6B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CD40-CD40L interactions in atherosclerosis.
@ast
CD40-CD40L interactions in atherosclerosis.
@en
CD40-CD40L interactions in atherosclerosis.
@nl
type
label
CD40-CD40L interactions in atherosclerosis.
@ast
CD40-CD40L interactions in atherosclerosis.
@en
CD40-CD40L interactions in atherosclerosis.
@nl
prefLabel
CD40-CD40L interactions in atherosclerosis.
@ast
CD40-CD40L interactions in atherosclerosis.
@en
CD40-CD40L interactions in atherosclerosis.
@nl
P1476
CD40-CD40L interactions in atherosclerosis.
@en
P2093
Esther Lutgens
Mat J A P Daemen
P356
10.1016/S1050-1738(01)00142-6
P577
2002-01-01T00:00:00Z